Vagus Nerve Stimulation
30
8
9
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.3%
1 terminated out of 30 trials
92.3%
+5.8% vs benchmark
0%
0 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (30)
How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?
The ENHANCE Study: taVNS and Psilocybin
Frequency-Dependent Effects of Auricular Vagus Nerve Stimulation on Autonomic and Cardiovascular Parameters
Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Cognitive Performance and Sex Differences
Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
Auricular Vagus Stimulation in Obesity
Technology Enhanced Adolescent Mental Health (TEAM)
Auricular Vagus Stimulation and Heart Rate Variability
Auricular Vagus Stimulation and STEMI
Transcutaneous Auricular Vagus Nerve Stimulation and Quality of Recovery After Major Noncardiac Surgery
taVNS Effect on Central Auditory Processing
Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding
Transcutaneous Auricular Vagus Nerve Stimulation Prevents Postoperative Delirium in Elderly Patients
Rehabilitation Paired with VNS for Motor Function Recovery
Effect of Vagus Nerve Stimulation Via the Outer Ear on Motor and Cognitive Deficits After Ischemic Stroke
Effects of tVNS on Visceral Pain
Transauricular Vagus Nerve Stimulation Improves Postoperative Sleep Disorders in Elderly Patients.
NAC +taVNS in IDM Who Are Poor Oral Feeders
Transauricular Vagal Nerve Stimulation Improves Postoperative Delirium in Elderly Patients
The Effect of Auricular Vagus Nerve Stimulation on EEG and EMG Measurement in Healthy Persons